Can personalized use of NSAIDs be a reality in the clinic?

Michael T. Nurmohamed

doi:10.1038/s41584-019-0225-7

Can personalized use of NSAIDs be a reality in the clinic?

Michael T. Nurmohamed

Amsterdam Rheumatology & Immunology Centre: Amsterdam UMC–Vrije Universiteit Amsterdam & Reade Rheumatology, Amsterdam, Netherlands

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?

Original language	English
Pages (from-to)	387-388
Journal	Nature Reviews Rheumatology
Volume	15
Issue number	7
DOIs	https://doi.org/10.1038/s41584-019-0225-7
Publication status	Published - 1 Jul 2019

Access to Document

10.1038/s41584-019-0225-7

Cite this

@article{d04b2a019ff348b8b11e673625665423,

title = "Can personalized use of NSAIDs be a reality in the clinic?",

abstract = "The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?",

author = "Nurmohamed, \{Michael T.\}",

year = "2019",

month = jul,

day = "1",

doi = "10.1038/s41584-019-0225-7",

language = "English",

volume = "15",

pages = "387--388",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",